What is Auxilium Pharmaceuticals?

Auxilium Pharmaceuticals recorded total sales of over $230 million in 2012 and trades on the NASDAQ American stock exchange as AUXL. It is manufactured in the form of a pellet, which is implanted by a health care provider underneath the patient’s skin in a fatty area.

What is Auxilium investment service?

The Auxilium Investment Service is a streamlined investment service designed to help you build wealth. The Service offers a wide range of investment options to help you meet your financial objectives. It also offers administrative ease, competitive pricing and consolidated reporting.

Are institutions buying amylyx Pharmaceuticals stock?

Since institutions own only a small portion of Amylyx Pharmaceuticals, many may not have spent much time considering the stock. But it's clear that some have; and they liked it enough to buy in. So if the company itself can improve over time, we may well see more institutional buyers in the future.